FDA 483 - InSightec, Ltd. - November 27, 2017

The provided document outlines the foundational aspects of an FDA Form 483, which is issued by the Food and Drug Administration to report objectionable conditions or practices observed during an inspection. Its primary purpose is to assist inspected firms in complying with federal regulations and is mandated under Section 704(b) of the Federal Food, Drug and Cosmetic Act (21 USC 374(b)). This section stipulates that an FDA officer must provide a written report to the establishment's owner or agent detailing any conditions that indicate a product may be adulterated or prepared under unsanitary conditions, rendering it injurious to health. The text clarifies that the report serves to highlight findings that, in the inspector's judgment, require attention. However, the provided content is a general explanation of the FDA 483 form's regulatory context and purpose, and does not include specific details such as a company name, inspection dates, main violations or issues identified, or any required corrective actions for a particular establishment. It also refers to a FOIA request, indicating the document's release method.